Hennion & Walsh Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $672K | Buy |
274,259
+24,733
| +10% | +$60.6K | 0.03% | 589 |
|
|
2025
Q1 | $1.66M | Buy |
249,526
+12,027
| +5% | +$80.2K | 0.07% | 324 |
|
|
2024
Q4 | $2.99M | Buy |
237,499
+16,453
| +7% | +$207K | 0.14% | 190 |
|
|
2024
Q3 | $4.08M | Buy |
221,046
+16,936
| +8% | +$313K | 0.19% | 129 |
|
|
2024
Q2 | $4.39M | Sell |
204,110
-27,177
| -12% | -$585K | 0.23% | 98 |
|
|
2024
Q1 | $6.23M | Buy |
231,287
+37,937
| +20% | +$1.02M | 0.33% | 52 |
|
|
2023
Q4 | $5.79M | Buy |
193,350
+42,276
| +28% | +$1.27M | 0.33% | 60 |
|
|
2023
Q3 | $3.1M | Buy |
151,074
+25,845
| +21% | +$530K | 0.2% | 126 |
|
|
2023
Q2 | $2.49M | Buy |
125,229
+21,597
| +21% | +$429K | 0.15% | 184 |
|
|
2023
Q1 | $1.78M | Buy |
103,632
+4,641
| +5% | +$79.5K | 0.11% | 230 |
|
|
2022
Q4 | $1.94M | Buy |
98,991
+40,919
| +70% | +$801K | 0.12% | 215 |
|
|
2022
Q3 | $927K | Buy |
58,072
+14,460
| +33% | +$231K | 0.06% | 344 |
|
|
2022
Q2 | $600K | Buy |
+43,612
| New | +$600K | 0.04% | 449 |
|